MindWalk Holdings (HYFT) Enterprise Value (2020 - 2026)
MindWalk Holdings (HYFT) posted quarterly Enterprise Value of -$8.4 million for Q2 2026, down 10.29% year-over-year from -$9.3 million in Q2 2025, and up 17.45% quarter-over-quarter from -$10.1 million in Q1 2026.
Analysis
MindWalk Holdings (HYFT) Enterprise Value (2020 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has reported Enterprise Value for 7 consecutive years, with -$8.4 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Enterprise Value fell 10.29% year-over-year to -$8.4 million; the TTM figure through Apr 2026 stood at -$8.4 million (down 10.29% YoY), while the FY2026 annual figure was -$8.4 million, down 7.96% from the prior year.
- Enterprise Value rose to -$8.4 million in Q2 2026 per HYFT's latest filing, from -$10.1 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$2.6 million in Q2 2024 and bottomed at -$26.1 million in Q1 2022.
- Historically, Enterprise Value has averaged -$9.1 million across 5 years, with a median of -$8.0 million in 2026.
- Annual changes were most pronounced in 2023 — Enterprise Value jumped 73.94% — and 2025, when it plunged 348.79%.
- MindWalk Holdings' Enterprise Value stood at -$11.3 million in 2022, then soared by 60.3% to -$4.5 million in 2023, then surged by 41.1% to -$2.7 million in 2024, then tumbled by 348.79% to -$11.9 million in 2025, then climbed by 29.66% to -$8.4 million in 2026.
- Business Quant data shows HYFT's Enterprise Value at -$8.4 million in Q2 2026, -$10.1 million in Q1 2026, and -$11.9 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | MindWalk Holdings | 61.22 Mn | 52.95 Mn | 1.82 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 47.31 Mn |
| Jan 31, 2026 | 43.94 Mn |
| Oct 31, 2025 | 50.53 Mn |
| Jul 31, 2025 | 51.86 Mn |
| Apr 30, 2025 | 7.13 Mn |
| Jan 31, 2025 | 3.37 Mn |
| Oct 31, 2024 | 10.20 Mn |
| Jul 31, 2024 | 18.34 Mn |
| Apr 30, 2024 | 31.87 Mn |
| Jan 31, 2024 | 40.69 Mn |
| Oct 31, 2023 | 53.21 Mn |
| Jul 31, 2023 | 58.02 Mn |
| Apr 30, 2023 | 58.20 Mn |
| Jan 31, 2023 | 78.17 Mn |
| Oct 31, 2022 | 86.51 Mn |
| Jul 31, 2022 | 68.32 Mn |
| Apr 30, 2022 | 85.74 Mn |
| Jan 31, 2022 | 92.40 Mn |
| Oct 31, 2021 | 95.43 Mn |
| Jul 31, 2021 | 93.00 Mn |